Keyphrases
COVID-19
100%
RNA Virus
100%
Antiviral Efficacy
40%
Antiviral Activity
40%
Small Molecule Inhibitors
40%
Nucleic Acid Therapeutics
40%
Peptoid
20%
Lead Identification
20%
Selective Degradation
20%
Pandemic Virus
20%
Lead Optimization
20%
Support Matching
20%
Natural Resource Industries
20%
Nucleic Acid Targets
20%
Circular RNA
20%
Conserved RNA Structure
20%
Lethal mutagenesis
20%
NSP4
20%
Planned Activities
20%
CoV-2
20%
Philanthropy
20%
Viral
20%
Lead Molecules
20%
Institutional Support
20%
Preclinical Development
20%
Action Targets
20%
Locked nucleic Acid
20%
Pandemic Potential
20%
Coronavirus
20%
Antisense Oligonucleotides
20%
Direct-acting Antivirals
20%
Biosafety
20%
Containment
20%
Nucleoside Analogues
20%
Viral Genome
20%
RNA Replication
20%
Structural Biology
20%
Viral Proteins
20%
Industry Collaboration
20%
Exonuclease
20%
Small Molecule Therapeutics
20%
Small Molecules
20%
Formulation Method
20%
Mode of Delivery
20%
Viral Envelope
20%
Selective Inhibitor
20%
Antiviral Target
20%
Protein Targeting
20%
Membrane-associated
20%
Virus
20%
Access to Facilities
20%
Mechanism of Action
20%
Antiviral Peptides
20%
SARS-CoV-2 Main Protease
20%
Protein Therapeutics
20%
Medicine and Dentistry
Outpatient
100%
Virus RNA
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Antivirus Agent
100%
Nucleic Acid
22%
Virus
22%
Rigor
11%
RNA Structure
11%
Exonuclease
11%
Antisense Oligonucleotide
11%
Virus Envelope
11%
Target Protein
11%
RNA Replication
11%
Proteinase
11%
Locked Nucleic Acid
11%
Antiviral Activity
11%
Viral Protein
11%
Mutagenesis
11%
Virus Genome
11%
Peptoid
11%
Coronavirus
11%
Antiviral Drug
11%
Ribonucleoside
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
SARS Coronavirus
100%
Virus RNA
100%
Nucleic Acid
22%
Mutagenesis
11%
Proteinase
11%
Locked Nucleic Acid
11%
Antiviral Drug
11%
Antiviral Activity
11%
Peptoid
11%
Ribonucleoside
11%
Viral Protein
11%
Rigor
11%
Antisense Oligonucleotide
11%
Exonuclease
11%